Диссертация (1146691), страница 18
Текст из файла (страница 18)
343349.159.Mohammad, A. Long-Term Clinical Outcome of Sirolimus-ElutingStent Implantation in Metabolic Syndrome and Diabetes /A. Mohammad [etal.]// Issue.- 2010.- Vol. 22.- P. 210-224.160.Mozejko-Pastewka, B. Retrospective analysis of cardiovascular out-comes in patients with type 2 diabetes mellitus after the first acute myocardial infarction / B.
Mozejko-Pastewka [et al.]//Acta Diabetologica. 2003.Vol. 40, №2.- P. 354-357.161.Muñoz Roldán I. Cardiovascular risk in patients with diabetes type 2with or without associated metabolic syndrome / Muñoz Roldán I [et al.]//Clinica e Investigacion en Arteriosclerosis.- 2011.- Vol. 23, № 3.- P. 112118.162.Natali, A. Coronary atherosclerosis in type ii diabetes: angiographicfindings and clinical outcome / A. Natali [et al.]// Diabetologia.- 2000.- Vol.43, № 5.- P. 632-641.163.Negassa, A. Inter-heart: a global study of risk factors for acute myo-cardial infarction / A. Negassa [et al.]// American Heart Journal.- 2001.Vol.
141, № 5.- P. 711-721.164.Ness, J. Prevalence of coronary artery disease, ischemic stroke, andsymptomatic peripheral arterial disease and of associated risk factors in older men and women with and without diabetes mellitus / J. Ness, W. S. Aronow, C. Ahn//Preventive Cardiology.- 2000.- Vol. 3, № 4.- P. 160-162.112165.Nigam, A. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease / A. Nigam [et al.]//American Heart Journal.- 2006.- Vol. 151, № 2.- P.
514-521.166.Nishioa, K. Insulin resistance as a predictor for restenosis after coro-nary stenting / K. Nishioa [et al.] // International Journal of Cardiology.2005.- Vol. 103.- P. 128-134.167.Paula, E. A. Cardiovascular risk assessment in hypertensive patients /E. A. Paula [et al]// Revista Latino-Americano de Enfermagem.- 2013.- Vol.21, № 3.168.Persic, V. Obesity in the cardiovascular continuum/ V. Persic//Current Clinical Pharmacology.- 2013.- Vol. 8, № 2.- P. 159-163.169.Povel, C.
M. Metabolic syndrome model definitions predicting type 2diabetes and cardiovascular disease / C. M. Povel [et al.]// Diabetes Care.2013.- Vol. 36, № 2.- P. 362-368.170.Prasad, K. C-reactive protein and cardiovascular diseases / K. Prasad//International Journal of Angiology.- 2003.- Vol. 12, № 1.- P. 1-12.171.Proscia, C. Impact of glycemic abnormalities on coronary artery dis-ease / C. Proscia [et al.]// Current Topics in Pharmacology.- 2013.- Vol. 17,№ 2.- P. 75-93.172.Przewlocki T.
Long-term outcome of coronary balloon angioplasty indiabetic patients / T. Przewlocki [et al.]// International Journal of Cardiology.- 2000.- Vol. 76, № 1.- P. 7-16.173.Rana, J. S. Metabolic Syndrome and Risk of Restenosis in PatientsUndergoing Percutaneous Coronary Intervention / J. S. Rana [et al.] // Diabetes Care.- 2005.- Vol. 28.- P. 873-877.113174.Raposo, L. Metabolic score — a simple risk marker in non-st eleva-tion acute coronary syndromes / L. Raposo [et al.]// Revista Portuguesa deCardiologia.- 2006.- Vol.
25, № 2.- P. 155-171.175.Rasouli, N. Adipocytokines and the Metabolic Complications of Obe-sity/ N. Rasouli, P.A. Kern// J Clin Endocrinol Metab.- 2008.- Vol. 93.- Р.64-73.176.Reaven, G. M. Role of insulin resistance in human disease/ G. M.Reaven// Diabetes.- 1988.- Vol. 37.- P. 1595-1607.177.Roffi, M. Percutaneous coronary intervention in diabetic patients withnon-ST-segment elevation acute coronary syndromes/ M. Roffi, E. J.
Topol//European Heart Journal.- 2004.- Vol. 25, № 3.- P. 190.178.Ryo, M. Adiponectin as a biomarker of the metabolic syndrome /RyoM [et al.]//Circ.-2004.- Vol. 68.- Р. 975-981.179.Schofer, J. Are drug-eluting stents a panacea for patients with coro-nary heart disease?/ J. Schofer// The Lancet.- 2004.- Vol. 364, № 9434.- С.558-559.180.Schwartz, G.G. Relation of Characteristics of Metabolic Syndrome toShort-Term Prognosis and Effects of Intensive Statin Therapy After AcuteCoronary Syndrome /G.G. Schwartz [et al.]// Diabetes Care.- 2005.- Vol.28.- P. 2508-2513.181.Scott, C. L. Diagnosis, prevention, and intervention for the metabolicsyndrome / C.
L. Scott // The American Journal of Cardiology.- 2003.- Vol.92, № 1.- P. 35.182.Shalimova, A. S. Contribution of type 2 diabetes to the developmentof heart and vessels remodeling in patients with essential hypertension / A.S. Shalimova// New Armenian Medical Journal.- 2014. Vol. 8, № 2.- P. 3339.114183.Shimizu, H. The leptin-dependent and independent melanocortin sig-naling system: regulation of feeding and energy expenditure/ H. Shimizu, K.Inoue, M. Mori// J Endocrinol.- 2007.- Vol. 193.- P. 1—9.184.Sidorenkov, O. Metabolic syndrome in russian adults: associated fac-tors and mortality from cardiovascular diseases and all causes / O. Sidorenkov, O. Nilssen, A. M.
Grjibovski// BMC Public Health.- 2010.- Vol. 10.- P.582.185.Singh, R. B. Acute coronary syndrome: a progression of pre-metabolicsyndrome/ R. B. Singh [et al.]// World Heart Journal.- 2008.- Vol. 1, № 4.P. 307-308.186.Singh, R. B. Prevalence of type 2 diabetes mellitus and risk of hyper-tension and coronary artery disease in rural and urban population with lowrates of obesity / R. B.
Singh [et al.]// International Journal of Cardiology.1998.- Vol. 66, № 1.- P. 65-72.187.Socioeconomic factors as predictors of incident heart failure/E. In-gelsson [et al.]// J Card Fail.- 2006.- Vol. 12.- P. 540-545.188.Sosnowski, C. Primary coronary intervention in diabetic octogenari-ans with acute st elevation myocardial infarction / C.
Sosnowski [et al.]//Kardiologia Polska.- 2007.- Vol. 65, № 10.- P. 1181-1186.189.Spenser, C. P. Is there a menopause metabolic syndrome / C. P. Spen-ser, I. F. Godsland, С. Stevenson //Gynecol. Endocrinol.- 1997.- Vol. 11.- P.341-345.190.Srikanth, S. Hypertension as a cardiometabolic risk / S. Srikanth, P.Deedwania//Indian Heart Journal.- 2010.- Vol. 62, № 5.- P. 394-401.191.Stettler, C. Outcomes associated with drug-eluting and bare-metalstents: a collaborative network meta-analysis / C. Stettler [et al.]// The Lancet.- 2007.-Vol. 370.- P.
937-948.115192.Stone, G. Comparison of angiography with stenting in acute myocar-dial infarction/ G. Stone [et al.]//N Engl J Med.- 2002.- Vol. 346.Р. 957-966.193.Svensson, A. M. Association between hyper- and hypoglycaemia and2 year all-cause mortality risk in diabetic patients with acute coronaryevents/ A. M. Svensson [et al.]//European Heart Journal.- 2005.- Vol.
26, №13.- P. 1255.194.Syed, Z. Computationally generated cardiac biomarkers for risk strati-fication after acute coronary syndrome/ Z. Syed [et al.]// Science Translational Medicine.- 2011. Vol. 3, № 102.- P. 102.195.Taizhanova, D. Z. Estimation of risk factors of restenosis after coro-nary revascularization / D.
Z. Taizhanova [et al.]// European Journal of Natural History.- 2013.- Vol. 6.- P. 18-19.196.Tas, S. Blood pressure, coronary artery disease, and glycaemic controlin type 2 diabetes mellitus:.../ S. Tas, N. A. Abdella// The Lancet.- 1994.Vol. 343, № 8907.- С. 1194-1195.197.The metabolic syndrome and total and cardiovascular disease mortali-ty in middle-aged men/ H.M. Lakka [et al.] // JAMA. — 2002. — Vol. 288.— P. 2709-2716.198.Tin, L. L. Hypertension, left ventricular hypertrophy, and suddendeath / L.
L. Tin, D. Gareth Beevers, G. Y. H. Lip// Current Cardiology Reports.- 2002.- Vol. 4, № 6.- P. 449-457.199.Tschoepe, D. Heart disease and metabolic syndrome/ D. Tschoepe, P.Roesen, W. A. Scherbaum// Zeitschrift für Kardiologie.- 1999.- Vol. 88, №3.- P. 215-224.200.Uchida, Y.
Impact of metabolic syndrome on various aspects of mi-crocirculation and major adverse cardiac events in patients with ST-segmentelevation myocardial infarction/ Y. Uchida [et al.]// Circ J.- 2012.- Vol. 76.Р. 1972-1979.116201.Van De Graaff, E. Gender-specific risk factors for thromboembolicstroke with acute myocardial infarction / E. Van De Graaff [et al.]// Journalof the American College of Cardiology.- 2003.- Vol.
41, № 6.- P. 375-376.202.Wang, J. The metabolic syndrome predicts cardiovascular mortality: a13-year follow-up study in elderly non-diabetic finns / J. Wang [et al.]// European Heart Journal.- 2007.- Vol. 28, № 7.- P. 857.203.Wassink, A. M. J. Metabolic syndrome and the risk of new vascularevents and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm/ A.
M. J. Wassink [et al.]// European Heart Journal.- 2008.- Vol. 29, № 2.P. 213.204.Wilson, P.W.F. Risk of type 2 diabetes mellitus and coronary heartdisease: a pivotal role for metabolic factors / P.W.F.Wilson, Ja.B.Meigs//European Heart Journal, Supplement.- 2008.- Vol. 10.-P.
11.205.Xu, D. The angiographic and clinical outcomes after coronary stentingin patients with metabolic syndrome/ D. Xu [et al.]//Atherosclerosis.- 2012.Vol. 221.- P. 416-421.206.Yatagai, T. Hypoadiponectinemia is associated with visceral fat ac-cumulation and insulin resistance in Japanese men with type 2 diabetesmellitus/ Yatagai T. [et al.]// Metabolism.- 2003.- Vol.
52.- Р.1274-1278.207.Yosefy, C. Hyperglycaemia and its relation to cardiovascular morbidi-ty and mortality: has it been resolved? / Yosefy C.// Acta Diabetologica.2003.- Vol. 40, №2.- P. 380-388.208.Yudkin, J. S. Determinants of hospital admission and case fatality indiabetic patients with myocardial infarction / J.
S. Yudkin, G. A. Oswald//Diabetes Care.- 1988.- Vol. 11.- P. 351-358.117209.Zeller, M. Prevalence and Impact of Metabolic Syndrome on HospitalOutcomes in Acute Myocardial Infarction/ M. Zeller [et al.]// Arch. In tern.Med.- 2005.- Vol. 165.- P. 1192-1198.210.Zornitzki T. Diabetes, but not the metabolic syndrome, predicts theseverity and extent of coronary artery disease in women / T. Zornitzki [etal.]// QJM: An International Journal of Medicine.- 2007.- Vol. 100, № 9.- P.575..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
